Plain-English translation of NCT06638320 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study—meaning researchers are not testing a new medication, but instead gathering information from people who already have chronic hepatitis B. The goal is to find out how many of these patients also have hepatitis D virus infection, which types are most common, and what risk factors might make someone more likely to develop it.
Hepatitis D only infects people who already have hepatitis B, and it can cause more severe liver disease. By understanding how common it is and who is at highest risk, doctors can better screen for it and help protect patients.
You likely qualify if…
You likely don't qualify if…
You will have a one-time visit where a researcher will ask you questions about your medical history, lifestyle, vaccinations, and family background using a questionnaire. A blood sample will also be collected during this visit. The study is observational, meaning you will not receive any experimental treatment—researchers are simply gathering information to learn more about hepatitis D in people with hepatitis B.
AI-generated summary from trial data · Aug 4, 2026 · Not medical advice
Vietnam
Sponsor
Tam Anh Research Institute
Enrollment target
~2,452 participants
Started
November 2024
Primary completion
November 2026
Age range
16 Years and older
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Loc Tho Truong, MSc
Tam Anh Research Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.